Cargando…
Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy
We present here the development of multifunctional doxorubicin (DOX)-conjugated poly(amidoamine) (PAMAM) dendrimers as a unique platform for pH-responsive drug release and targeted chemotherapy of cancer cells. In this work, we covalently conjugated DOX onto the periphery of partially acetylated and...
Autores principales: | Zhang, Mengen, Zhu, Jingyi, Zheng, Yun, Guo, Rui, Wang, Shige, Mignani, Serge, Caminade, Anne-Marie, Majoral, Jean-Pierre, Shi, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160908/ https://www.ncbi.nlm.nih.gov/pubmed/30235881 http://dx.doi.org/10.3390/pharmaceutics10030162 |
Ejemplares similares
-
New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers
por: Mignani, Serge, et al.
Publicado: (2018) -
Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin
por: Qiu, Jieru, et al.
Publicado: (2018) -
Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates
por: Pyreddy, Suneela, et al.
Publicado: (2014) -
Which Dendrimer to Attain the Desired Properties? Focus on Phosphorhydrazone Dendrimers†
por: Caminade, Anne-Marie, et al.
Publicado: (2018) -
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs
por: Mignani, Serge, et al.
Publicado: (2021)